Literature DB >> 31930074

Effect of Candida albicans bronchial colonization on hospital-acquired bacterial pneumonia in patients with systemic lupus erythematosus.

Yuetian Yu1,2, Jia Li1, Suli Wang1, Yuan Gao2, Hui Shen3, Liangjing Lu1.   

Abstract

BACKGROUND: To investigate the effect of Candida albicans airway colonization on hospital-acquired bacterial pneumonia (HABP) in patients with systemic lupus erythematosus (SLE).
METHODS: SLE patients with HAP were enrolled in this retrospective cohort study from January 2015 to December 2018. According to the culture results of respiratory tract secretions and antifungal treatment, patients were divided into non-C. albicans colonization group (NCG), C. albicans colonization with antifungal treatment group (CTG) and C. albicans colonization without antifungal treatment group (CNTG). Twenty-eight days of all-cause mortality after the onset of HABP of each group was assessed, total duration of antibiotic treatment, changes of inflammatory cytokines and markers of immune status were documented.
RESULTS: A total of 269 SLE patients with HABP were finally included in the study. Among them, 69.1% (186/269) were found C. albicans airway colonization, and 36.1% (97/269) received antifungal treatment. No difference of 28 days of all-cause mortality after HABP onset was found among the three groups (10.8% vs. 13.4% vs. 15.7%, P>0.05). Duration of antibiotic treatment of HABP due to Acinetobacter baumannii was shorter in CTG (11.21±2.45 days) than that in CNTG (12.89±3.87 days) as well as HABP due to Pseudomonas aeruginosa (10.57±2.66 vs. 12.56±3.04 days) (P<0.05, respectively). Antifungal treatment could decrease the level of interleukin-1β, interleukin-6, tumor necrosis factor-α and interferon-γ in CTG than in CNTG (P<0.05, respectively). In addition, it could regulate immune function by decrease the concentration of interleukin-17 and elevate the counts of CD4+Th lymphocyte as well (P<0.05, respectively).
CONCLUSIONS: C. albicans airway colonization was not associated with HABP mortality in SLE patients. Antifungal therapy in these patients might shorten the duration of antibiotics in treating HABP due to A. baumannii and P. aeruginosa. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Candida albicans; colonization; hospital-acquired pneumonia; immunocompromised host (ICH); systemic lupus erythematosus (SLE)

Year:  2019        PMID: 31930074      PMCID: PMC6944617          DOI: 10.21037/atm.2019.10.44

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  25 in total

Review 1.  Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria.

Authors:  Clayton W Hall; Thien-Fah Mah
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

2.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

3.  Agent-based model of diffusion of N-acyl homoserine lactones in a multicellular environment of Pseudomonas aeruginosa and Candida albicans.

Authors:  Gael Pérez-Rodríguez; Sónia Dias; Martín Pérez-Pérez; Florentino Fdez-Riverola; Nuno F Azevedo; Anália Lourenço
Journal:  Biofouling       Date:  2018-03-08       Impact factor: 3.209

4.  Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study.

Authors:  Jean-Francois Timsit; Carole Schwebel; Lenka Styfalova; Muriel Cornet; Philippe Poirier; Christiane Forrestier; Stéphane Ruckly; Marie-Christine Jacob; Bertrand Souweine
Journal:  Intensive Care Med       Date:  2019-04-24       Impact factor: 17.440

5.  Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail.

Authors:  Damien Roux; Stéphane Gaudry; Linda Khoy-Ear; Meryem Aloulou; Mathilde Phillips-Houlbracq; Julie Bex; David Skurnik; Erick Denamur; Renato C Monteiro; Didier Dreyfuss; Jean-Damien Ricard
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

6.  Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.

Authors:  Christina E Zielinski; Federico Mele; Dominik Aschenbrenner; David Jarrossay; Francesca Ronchi; Marco Gattorno; Silvia Monticelli; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nature       Date:  2012-04-26       Impact factor: 49.962

7.  Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia.

Authors:  Elie Azoulay; Jean-François Timsit; Muriel Tafflet; Arnaud de Lassence; Michael Darmon; Jean-Ralph Zahar; Christophe Adrie; Maité Garrouste-Orgeas; Yves Cohen; Bruno Mourvillier; Benoît Schlemmer
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

8.  Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paula Peyrani; Giovanni Filardo; Mehdi Mirsaeidi; Asad Amir; Francesco Blasi; Julio A Ramirez
Journal:  Chest       Date:  2011-02-17       Impact factor: 9.410

Review 9.  Candida albicans interactions with bacteria in the context of human health and disease.

Authors:  Diana K Morales; Deborah A Hogan
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

10.  Microbiological findings in bronchoalveolar lavage fluid from lung transplant patients in Sweden.

Authors:  Anna Stjärne Aspelund; Helena Hammarström; Malin Inghammar; Hillevi Larsson; Lennart Hansson; Gerdt C Riise; Vanda Friman; Bertil Christensson; Lisa I Påhlman
Journal:  Transpl Infect Dis       Date:  2018-08-27       Impact factor: 2.228

View more
  3 in total

Review 1.  Candida Pneumonia: An Innocent Bystander or a Silent Killer?

Authors:  Durga Shankar Meena; Deepak Kumar
Journal:  Med Princ Pract       Date:  2021-10-12       Impact factor: 1.927

2.  Teasaponin suppresses Candida albicans filamentation by reducing the level of intracellular cAMP.

Authors:  Ying Li; Mingzhu Shan; Shihui Li; Yuechen Wang; Huan Yang; Ying Chen; Bing Gu; Zuobin Zhu
Journal:  Ann Transl Med       Date:  2020-03

3.  A bibliometric analysis of infectious diseases in patients with liver transplantation in the last decade.

Authors:  Han Zhong; Chun-Yan Liu; You-Qin Dai; Cheng Zhu; Ke-Jia Le; Xiao-Yun Pang; Yu-Jie Li; Zhi-Chun Gu; Yue-Tian Yu
Journal:  Ann Transl Med       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.